ID

33609

Description

BIOFLOW III Satellite-ELADIS; ODM derived from: https://clinicaltrials.gov/show/NCT02029092

Link

https://clinicaltrials.gov/show/NCT02029092

Keywords

Versions (1)
  1. 12/15/18 12/15/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 15, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Coronary Artery Disease NCT02029092

English

Eligibility Coronary Artery Disease NCT02029092

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
symptomatic coronary artery disease
Description

Coronary Artery Disease Symptomatic

Data type

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C0231220
subject has signed informed consent for data release
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
subject is geographically stable and willing to participate at all follow up assessments
Description

Study Subject Geographic Stable | Participation Follow-up Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C1517526
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0679823
UMLS CUI [2,2]
C3274571
UMLS CUI [2,3]
C0600109
subject is≥18 years of age.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject did not sign informed consent for data release
Description

Informed Consent Lacking

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0332268
pregnancy
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation, antiplatelet therapy required for pci, stainless steel, sirolimus or contrast media.
Description

Intolerance to Aspirin | Intolerance to Clopidogrel | Intolerance to Ticlopidine | Intolerance to Heparin | Intolerance Anticoagulation Therapy | Intolerance Antiplatelet therapy | Antiplatelet therapy Requirement Percutaneous Coronary Intervention | Intolerance to Stainless Steel | Intolerance to Sirolimus | Intolerance to Contrast Media

Data type

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0004057
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0070166
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0040207
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0019134
UMLS CUI [5,1]
C0231199
UMLS CUI [5,2]
C0003281
UMLS CUI [6,1]
C0231199
UMLS CUI [6,2]
C1096021
UMLS CUI [7,1]
C1096021
UMLS CUI [7,2]
C1514873
UMLS CUI [7,3]
C1532338
UMLS CUI [8,1]
C1744706
UMLS CUI [8,2]
C0038126
UMLS CUI [9,1]
C1744706
UMLS CUI [9,2]
C0072980
UMLS CUI [10,1]
C1744706
UMLS CUI [10,2]
C0009924
planned surgery within 6 months after pci unless dual antiplatelet therapy will be maintained
Description

Operative Surgical Procedures Planned | Exception Maintenance Antiplatelet therapy Dual

Data type

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C1301732
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0024501
UMLS CUI [2,3]
C1096021
UMLS CUI [2,4]
C0205173
currently participating in another study and primary endpoint is not yet reached.
Description

Study Subject Participation Status | End Point Primary Lacking

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C2349179
UMLS CUI [2,2]
C0205225
UMLS CUI [2,3]
C0332268
Back to the top of the page

Similar models

Eligibility Coronary Artery Disease NCT02029092

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Coronary Artery Disease Symptomatic
Item
symptomatic coronary artery disease
boolean
C1956346 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Informed Consent
Item
subject has signed informed consent for data release
boolean
C0021430 (UMLS CUI [1])
Study Subject Geographic Stable | Participation Follow-up Willing
Item
subject is geographically stable and willing to participate at all follow up assessments
boolean
C0681850 (UMLS CUI [1,1])
C1517526 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0679823 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Age
Item
subject is≥18 years of age.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Informed Consent Lacking
Item
subject did not sign informed consent for data release
boolean
C0021430 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Intolerance to Aspirin | Intolerance to Clopidogrel | Intolerance to Ticlopidine | Intolerance to Heparin | Intolerance Anticoagulation Therapy | Intolerance Antiplatelet therapy | Antiplatelet therapy Requirement Percutaneous Coronary Intervention | Intolerance to Stainless Steel | Intolerance to Sirolimus | Intolerance to Contrast Media
Item
known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation, antiplatelet therapy required for pci, stainless steel, sirolimus or contrast media.
boolean
C1744706 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0040207 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0019134 (UMLS CUI [4,2])
C0231199 (UMLS CUI [5,1])
C0003281 (UMLS CUI [5,2])
C0231199 (UMLS CUI [6,1])
C1096021 (UMLS CUI [6,2])
C1096021 (UMLS CUI [7,1])
C1514873 (UMLS CUI [7,2])
C1532338 (UMLS CUI [7,3])
C1744706 (UMLS CUI [8,1])
C0038126 (UMLS CUI [8,2])
C1744706 (UMLS CUI [9,1])
C0072980 (UMLS CUI [9,2])
C1744706 (UMLS CUI [10,1])
C0009924 (UMLS CUI [10,2])
Operative Surgical Procedures Planned | Exception Maintenance Antiplatelet therapy Dual
Item
planned surgery within 6 months after pci unless dual antiplatelet therapy will be maintained
boolean
C0543467 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0024501 (UMLS CUI [2,2])
C1096021 (UMLS CUI [2,3])
C0205173 (UMLS CUI [2,4])
Study Subject Participation Status | End Point Primary Lacking
Item
currently participating in another study and primary endpoint is not yet reached.
boolean
C2348568 (UMLS CUI [1])
C2349179 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial